Tested Applications
| Positive WB detected in | human plasma |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20269-1-AP targets Factor XIIIb in WB, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | coagulation factor XIII, B polypeptide |
| Calculated Molecular Weight | 76 kDa |
| Observed Molecular Weight | ~80 kDa |
| GenBank Accession Number | NM_001994 |
| Gene Symbol | Factor XIIIb |
| Gene ID (NCBI) | 2165 |
| RRID | AB_3085601 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P05160 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Coagulation factor XIII (FXIII) is a blood proenzyme that catalyzes intermolecular cross-linking of fibrinogen and is involved in the clotting cascade. Factor XIII is composed of two catalytic FXIIIa and two protective/regulatory FXIIIb subunits. FXIIIb is the carrier/regulatory protein of its partner FXIIIa subunit. (PMID: 36372609; PMID: 1359667)
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for Factor XIIIb antibody 20269-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Factor XIIIb Polyclonal antibody (Cat# 20269-1-AP) has 1 citation to date. It was cited in Biomol Biomed (Impact Factor 2.8) in a 2024 study investigating F13B's role in regulating angiogenesis and tumor progression in hepatocellular carcinoma via the HIF-1α/VEGF pathway. The research field encompasses liver cancer biology, angiogenesis, and hypoxia signaling.
| Species | Application | Title |
|---|---|---|
Biomol Biomed F13B regulates angiogenesis and tumor progression in hepatocellular carcinoma via the HIF-1α/VEGF pathway
|

